Finance

Lists
Why is OPCH up 32.78%?
Dive Deeper
OPCH:NASDAQ
Option Care Health Inc
$31.03
+32.78%
(+7.66) 1D
Oct 6, 3:42:57 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OPCH...
Open
$31.04
High
$31.11
Low
$30.96
Mkt. cap
4.50B
Avg. vol.
1.98M
Volume
53.21M
P/E ratio
23.47
52-wk high
$36.79
52-wk low
$18.02
EPS
$1.32
Beta
0.58
Shares outstanding
149.78M
No. of employees
7K
Open
$31.04
High
$31.11
Low
$30.96
Mkt. cap
4.50B
Avg. vol.
1.98M
Volume
53.21M
P/E ratio
23.47
52-wk high
$36.79
52-wk low
$18.02
EPS
$1.32
Beta
0.58
Shares outstanding
149.78M
No. of employees
7K
News stories
From web sources and news partners
About Option Care Health Inc
CEO-
Employees7.4K
Founded1996
HeadquartersBannockburn, Illinois, United States
SectorHealth care provider
Websiteoptioncarehealth.com
Analyst ratings
Based on 7 analysts giving stock ratings to OPCH in the past 3 months
Buy
Buy
3
Hold
4
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for OPCH in the last 3 months.
Highest
Current $31.03
$33.00 (+6.35%)
Average
$25.80 (-16.85%)
Lowest
$23.00 (-25.88%)
Analyst
Recommendation
Action
Price target
Projected
Date
David S Macdonald
Truist Financial
Buy
Maintained
-
-
10/06/2026
Matt Larew
William Blair
Buy
Maintained
-
-
10/06/2026
Charles Rhyee
TD Cowen
Hold
Maintained
$23.00
-25.9%
08/02/2026
Michael Petusky
Barrington
Buy
Maintained
$33.00
+6.3%
07/30/2026
Joanna Gajuk
Bank of America Securities
Hold
Reiterated
$25.00
-19.4%
07/29/2026
Pito Chickering
Deutsche Bank
Hold
Downgraded
$24.00
-22.7%
07/30/2026
Kyle Evans
Stephens
Hold
Downgraded
$24.00
-22.7%
07/17/2026
Raj Kumar CFA
Stephens
Hold
Downgraded
$24.00
-22.7%
07/17/2026
A.J. Rice
UBS
Buy
Maintained
$39.00
+25.7%
06/16/2026
Scott Fidel
Goldman Sachs
Hold
Initiated
$22.00
-29.1%
06/08/2026
Erin Wright
Morgan Stanley
Buy
Maintained
$28.00
-9.8%
05/06/2026
Lisa Gill
J.P. Morgan
Buy
Reiterated
$33.00
+6.3%
05/04/2026
Constantine Davides
Citizens JMP
Buy
Maintained
$32.00
+3.1%
04/30/2026
Unknown Analyst
Jefferies
Buy
Maintained
$43.00
+38.6%
03/25/2026
Last report
Jul 29, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.45 / $0.43
+5.46%beat
Revenue / Est. (USD)
1.44B / 1.42B
+1.69%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.44B
1.47B
1.35B
1.44B
Cost of goods sold
1.16B
1.18B
1.09B
1.18B
Cost of revenue
1.16B
1.18B
1.09B
1.18B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
172.10M
172.14M
174.56M
164.66M
Operating expense
188.40M
191.40M
189.47M
182.11M
Total operating expenses
1.35B
1.37B
1.28B
1.36B
Operating income
84.51M
91.50M
72.54M
85.14M
Other non operating income
3.37M
-6.00M
1.78M
-532.00K
EBT including unusual items
68.97M
81.52M
61.00M
73.99M
EBT excluding unusual items
73.67M
81.52M
61.00M
73.99M
Income tax expense
17.15M
23.01M
15.66M
20.07M
Effective tax rate
24.87%
28.23%
25.67%
27.13%
Other operating expenses
-
-
-
-
Net income
51.82M
58.50M
45.34M
53.91M
Net profit margin
3.61%
3.99%
3.36%
3.74%
Earnings per share
0.45
0.46
0.40
0.45
Interest and investment income
-
-
-
-
Interest expense
-16.39M
-6.09M
-15.01M
-12.32M
Net interest expenses
-16.39M
-6.09M
-15.01M
-12.32M
Depreciation and amortization charges
16.29M
19.26M
14.91M
17.45M
EBITDA
101.56M
111.82M
88.20M
103.52M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps